Sign in

    International Flavors & Fragrances Inc (IFF)

    CFO Change
    Board Change

    You might also like

    International Flavors & Fragrances Inc. (IFF) is a leading creator and manufacturer of a diverse range of products used in consumer goods . The company operates through four main segments, offering natural-based ingredients, biotechnology-derived products, fragrance compounds, and pharmaceutical excipients . IFF's products serve various markets, including food, non-food, perfumes, household products, and industrial uses .

    1. Nourish - Offers natural-based ingredients that enhance nutritional value, texture, and functionality in food applications such as beverages, dairy, bakery, and confectionery.
    2. Health & Biosciences - Focuses on biotechnology-derived products like enzymes, probiotics, and specialty ingredients for both food and non-food applications, serving markets such as animal nutrition and grain processing.
    3. Scent - Produces fragrance compounds and ingredients used in perfumes and household products.
    4. Pharma Solutions - Provides pharmaceutical excipients and other specialty products for industrial uses.
    NamePositionStart DateShort Bio
    J. Erik FyrwaldChief Executive Officer and Board MemberFebruary 6, 2024J. Erik Fyrwald has served as the CEO and a member of the Board of Directors at IFF since February 6, 2024. He was previously CEO of Syngenta and held leadership roles at Univar Solutions and Nalco .
    Yuvraj AroraExecutive Vice President and President, NourishJune 19, 2023Yuvraj Arora joined IFF as Executive Vice President and President of Nourish in June 2023. He previously worked at Kellogg North America as President of U.S. categories .
    Deborah BorgExecutive Vice President, Chief Human Resources, Diversity & Inclusion and Communications OfficerAugust 29, 2022Deborah Borg has been with IFF since August 2022, previously serving as Chief Human Resources and Communications Officer at Bunge Limited .
    Michael DeVeauSenior Vice President, Corporate Finance and Investor RelationsDecember 2022Michael DeVeau has been with IFF since 2009 and became Senior Vice President, Corporate Finance and Investor Relations in December 2022. He will become Executive Vice President, Chief Financial Officer effective January 1, 2025 .
    Ralf FinzelExecutive Vice President, Global Operations OfficerNovember 1, 2022Ralf Finzel joined IFF in November 2022, previously serving as Vice President of Integrated Supply Chain at Honeywell International .
    Simon HerriottPresident, Health & Biosciences and ScentFebruary 2021Simon Herriott has been President, Health & Biosciences at IFF since February 2021 and took on additional responsibilities as President, Scent in July 2023 .
    Jennifer JohnsonExecutive Vice President, General Counsel and Corporate SecretaryFebruary 2021Jennifer Johnson has served as Executive Vice President, General Counsel and Corporate Secretary since February 2021, having joined DuPont's predecessor companies in 2013 .
    Glenn RichterExecutive Vice President, Chief Financial & Business Transformation OfficerFebruary 2023Glenn Richter has been with IFF since September 2021, initially as Chief Financial Officer. He will retire on December 31, 2024 .
    Angela StrzeleckiPresident, Pharma SolutionsFebruary 2021Angela Strzelecki has been President of Pharma Solutions since February 2021, having held various leadership roles at DuPont .
    Vic VermaExecutive Vice President, Chief Information OfficerFebruary 2021Vic Verma has been with IFF since 2016, becoming Executive Vice President, Chief Information Officer in February 2021 .
    Casper VroemenExecutive Vice President, Chief Research & Development OfficerSeptember 2023Casper Vroemen has been with the N&B Business since 2004 and became Executive Vice President, Chief Research & Development Officer in September 2023 .
    1. With the increased reinvestment needs in R&D and innovation, including the additional $20 million planned in Q3 and Q4 , how do you plan to balance this with your goal of continuously improving margins and ROIC, and can you provide more specifics on achieving both objectives?

    2. Given your net debt of $9.1 billion and a net debt to EBITDA ratio of 3.9x , what specific steps are you taking to strengthen your capital structure and reduce leverage, especially considering the upcoming divestiture of the Pharma Solutions business?

    3. With your updated full-year guidance expecting net sales of $11.3 billion to $11.4 billion and adjusted operating EBITDA at the high end of $2.1 billion to $2.17 billion , can you elaborate on the key risks that could prevent you from achieving these targets, particularly in light of potential macroeconomic headwinds?

    4. You mentioned a flat price/cost dynamic expected for next year ; can you provide more clarity on how you plan to manage potential increases in raw material costs and tariffs, and what impact these could have on your margins?

    5. Regarding the Functional Ingredients business turnaround and the ongoing restructuring of your global supply chain footprint , what key challenges do you foresee in achieving the targeted EBITDA margins of 15% plus, and how confident are you in meeting those targets within the planned timeframe?

    YearAmount Due (in millions)Debt TypeInterest Rate (%)% of Total Debt
    2024$468 2026 Term Loan Facility (current portion)5.21 5.1% = (468 / 9,099) * 100
    2025$1,000 2025 Notes1.22 11.0% = (1,000 / 9,099) * 100
    2026$892 2026 Euro Notes1.93 9.8% = (892 / 9,099) * 100
    2027$1,210 2027 Notes1.56 13.3% = (1,210 / 9,099) * 100
    2028$398 2028 Notes4.57 4.4% = (398 / 9,099) * 100
    2030$1,508 2030 Notes2.21 16.6% = (1,508 / 9,099) * 100
    2040$772 2040 Notes3.04 8.5% = (772 / 9,099) * 100
    2047$494 2047 Notes4.44 5.4% = (494 / 9,099) * 100
    2048$787 2048 Notes5.12 8.6% = (787 / 9,099) * 100
    2050$1,568 2050 Notes3.21 17.2% = (1,568 / 9,099) * 100

    Competitors mentioned in the company's latest 10K filing.

    • Givaudan, DSM-Firmenich Symrise, Kerry, ADM, Novonesis - Large global companies
    NameStart DateEnd DateReason for Change
    PricewaterhouseCoopers LLP1957 PresentCurrent auditor

    Recent developments and announcements about IFF.

    Corporate Leadership

      Leadership Change

      ·
      Dec 19, 2024, 9:34 PM

      Departures: Roger W. Ferguson, Jr., John Davidson, and Christina Gold will not stand for reelection at the 2025 Annual Meeting. Their decisions are not due to disagreements with the company . Gary Hu will step down from the Board on December 31, 2024, also without any disagreements .

      Appointments: Kevin O’Byrne will succeed Mr. Ferguson as Chair of the Board, subject to re-election . Cynthia Jamison, Dr. Mehmood Khan, and Vincent Intrieri will join the Board effective January 1, 2025 .

      Board Change

      ·
      Dec 19, 2024, 9:34 PM

      International Flavors & Fragrances Inc. (IFF) has announced several changes to its board of directors as of December 19, 2024. Roger W. Ferguson, Jr., John Davidson, and Christina Gold have decided not to stand for reelection at the 2025 Annual Meeting. Kevin O’Byrne is appointed to succeed Mr. Ferguson as Chair of the Board, effective at the 2025 Annual Meeting. Vincent Intrieri will replace Gary Hu as the Icahn Designee director, with Mr. Hu stepping down on December 31, 2024. Additionally, Cynthia Jamison, Dr. Mehmood Khan, and Vincent Intrieri have been appointed to the Board effective January 1, 2025 .

      Leadership Change

      ·
      Dec 10, 2024, 10:06 PM

      Who is leaving: Glenn Richter, the current Executive Vice President, Chief Financial Officer of International Flavors & Fragrances Inc. (IFF), is retiring effective December 31, 2024.

      Who is stepping up: Michael DeVeau has been appointed as the new Executive Vice President, Chief Financial Officer, effective January 1, 2025.

      Important details: Michael DeVeau has been with IFF since 2009, holding various senior finance leadership roles. His appointment includes a base salary of $700,000, an annual bonus target of 90% of his base salary, and a long-term incentive plan grant with a target value of $2,200,000, totaling $3,530,000 .

      CFO Change

      ·
      Dec 10, 2024, 10:06 PM

      Glenn Richter, the current Executive Vice President and Chief Financial Officer of International Flavors & Fragrances Inc. (IFF), will retire from the company effective December 31, 2024. Michael DeVeau has been appointed as the new CFO, effective January 1, 2025 .